Provides that certain actions taken by pharmacy benefits managers are deceptive or unfair trade practices.

Rhode Island Bill: Pharmacy Benefit Manager Practices

This bill targets pharmacy benefits managers (PBMs) — the companies that act as middlemen between insurance companies, pharmacies, and drug manufacturers. PBMs negotiate drug prices and decide which medications are covered under insurance plans. This legislation would classify certain actions by these companies as "deceptive or unfair trade practices" under Rhode Island's commercial laws, meaning those actions would be illegal and subject to legal consequences.

The bill affects several groups of people. Patients and consumers could benefit if the bill limits practices that restrict access to affordable medications or steer people toward more expensive options. Pharmacies, particularly independent and local drugstores, may benefit if the bill curbs PBM practices that critics say squeeze their reimbursement payments unfairly. Insurance plan sponsors, like employers who provide health benefits, could also be affected depending on how PBMs are required to change their business practices.

By labeling specific PBM behaviors as deceptive or unfair trade practices, the bill would give the state greater legal authority to hold these companies accountable and potentially allow harmed parties to seek remedies. Currently, the bill has been introduced and referred to the House Corporations Committee, meaning it is in the early stages of the legislative process and has not yet been voted on or signed into law.